|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn872115325 |
003 |
OCoLC |
005 |
20231120111532.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140310s1989 enka ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d KIJ
|d OCLCO
|d OPELS
|d YDXCP
|d E7B
|d OCLCF
|d EBLCP
|d OCLCQ
|d OCLCO
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d UKAHL
|d RDF
|d S2H
|d OCLCQ
|d VLY
|d LUN
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 855675843
|a 873140452
|a 878141970
|a 1116960698
|a 1162095095
|
020 |
|
|
|a 9781483183688
|q (electronic bk.)
|
020 |
|
|
|a 1483183688
|q (electronic bk.)
|
020 |
|
|
|a 1306480000
|q (ebk.)
|
020 |
|
|
|a 9781306480000
|q (ebk.)
|
020 |
|
|
|z 0723612714
|
020 |
|
|
|z 9780723612711
|
035 |
|
|
|a (OCoLC)872115325
|z (OCoLC)855675843
|z (OCoLC)873140452
|z (OCoLC)878141970
|z (OCoLC)1116960698
|z (OCoLC)1162095095
|
050 |
|
4 |
|a RM315
|
060 |
|
4 |
|a QV 76.5
|b B811i 1989
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.78
|2 22
|
084 |
|
|
|a 44.38
|2 bcl
|
100 |
1 |
|
|a Bradley, P. B.
|
245 |
1 |
0 |
|a Introduction to neuropharmacology /
|c Philip B. Bradley.
|
264 |
|
1 |
|a London ;
|a Boston :
|b Wright,
|c 1989.
|
300 |
|
|
|a 1 online resource (351 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 339-341) and index.
|
520 |
|
|
|a A pharmacological reference textbook which explains the characteristics of drug action and factors affecting human responses to drugs. Each drug affecting the peripheral and central nervous systems has been systematically outlined, with its individual characteristics and side effects.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Introduction to Neuropharmacology; Copyright Page; Preface; Introduction; Table of Contents; Part 1: General principles; Chapter 1. Characteristics of drug action; The kinetics of drug-receptor interactions; Dose-response relationships; Agonists; Drug antagonism; Partial agonists; Other ways of plotting dose-response relationships; Spare receptors; Chapter 2. Factors affecting responses to drugs; Absorption; Distribution; Metabolism; Excretion; Chapter 3. The principles of synaptic transmission; The neurone; Synaptic transmission; Criteria for synaptic transmitters.
|
505 |
8 |
|
|a Receptor-response mechanismsPresynaptic receptors; Part 2: The peripheral nervous system; Chapter 4. The somatic motor system; The somatic system; Chapter 5. Drugs affecting neuromuscular transmission; Drugs acting prejunctionally; Drugs which act postsynaptically; Drugs which prolong the actions of acetylcholine; Clinical uses of drugs affecting neuromuscular transmission; Venoms and toxins that affect neuromuscular transmission; Chapter 6. The autonomic nervous system; The subdivisions of the autonomic nervous system; Drugs affecting transmission in autonomic ganglia.
|
505 |
8 |
|
|a Chapter 7. Drugs affecting the parasympathetic systemDrugs mimicking parasympathetic stimulation; The pharmacological actions of muscarinic agonists; The clinical uses of muscarinic agonists; Muscarinic antagonists; The pharmacological actions of ant�imuscarinic drugs; The clinical uses of muscarinic antagonists; Atropine poisoning; Chapter 8. Drugs affecting the sympathetic system; Noradrenergic transmission; Receptors for catecholamines; Drugs with presynaptic actions; Drugs with agonist actions at adrenoceptors; The clinical uses of sympathomimetic drugs.
|
505 |
8 |
|
|a Drugs with antagonist actions on adrenoceptorsClinical uses of antagonist drugs; Chapter 9. Drugs with non-synaptic actions; Local anaesthetics; The clinical uses of local anaesthetic drugs; Veratnim alkaloids; Part 3: The central nervous system; Chapter 10. Synaptic transmission in the central nervous system; NEUROTRANSMITTERS IN THE CNS; Acetylcholine; Noradrenaline; Dopamine; 5-Hydroxytryptamine; Amino acids; Peptides; Miscellaneous putative neurotransmitters; Prostaglandins; CO-TRANSMISSION; Chapter 11. Anaesthetics, hypnotics and sedatives; General anaesthetics; Hypnotics and sedatives.
|
505 |
8 |
|
|a Chapter 12. Neuroleptic drugsThe classification of neuroleptic drugs; Effects of neuroleptic drugs on behaviour; The mechanism of action of neuroleptic drugs; The clinical uses of neuroleptic drugs; The dopamine hypothesis of schizophrenia; Chapter 13. Anti-anxiety drugs; Barbiturates; Benzodiazepines; Miscellaneous anti-anxiety drugs; The clinical uses of anti-anxiety drugs; Chapter 14. Anticonvulsant drugs; The classification of epileptic seizures; Drugs used in the treatment of epilepsy; The mechanism of action of anticonvulsant drugs; The clinical uses of anticonvulsant drugs.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Neuropharmacology.
|
650 |
|
2 |
|a Central Nervous System Agents
|x pharmacology
|0 (DNLM)D002491Q000494
|
650 |
|
2 |
|a Nervous System
|x drug effects
|0 (DNLM)D009420Q000187
|
650 |
|
2 |
|a Neuropharmacology
|0 (DNLM)D009480
|
650 |
|
6 |
|a Neuropharmacologie.
|0 (CaQQLa)201-0038270
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Neuropharmacology
|2 fast
|0 (OCoLC)fst01036458
|
650 |
|
7 |
|a Neuropharmacologie.
|2 fmesh
|
650 |
|
7 |
|a Syst�eme nerveux
|x Action des produits chimiques.
|2 fmesh
|
776 |
0 |
8 |
|i Print version:
|a Bradley, P.B.
|t Introduction to neuropharmacology
|z 0723612714
|w (DLC) 88026290
|w (OCoLC)18441467
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780723612711
|z Texto completo
|